Gefitinib and high-dose fractionated radiotherapy for carcinomatous encephalitis from non-small cell lung carcinoma.
Carcinomatous encephalitis is a rapidly fatal form of metastasis caused by miliary spread of systemic cancer into the brain parenchyma. The diagnostic criteria and optimal treatment for this disease are not well defined. We report a patient with rapid neurologic deterioration from carcinomatous encephalitis from lung adenocarcinoma. She was treated with gefitinib and high-dose fractionated whole brain radiotherapy, and eventually improved neurologically and was discharged home on hospital day 48. Gefitinib and high-dose fractionated radiotherapy may have synergistic activity in patients with carcinomatous encephalitis from non-small cell lung cancer having favorable prognostic factors. More importantly, timely recognition of this disease and the use of large fraction radiation therapy are necessary to control rapid neurologic deterioration.
Wong
Eric T
ET
Department of Neurology.
Wu
Julian K
JK
Mahadevan
Anand
A
J Clin Oncol. 2005 Apr 10;23(11):2493-501
15710947
JAMA. 2003 Oct 22;290(16):2149-58
14570950
J Clin Oncol. 2006 Sep 20;24(27):4517-20
16983123
Int J Radiat Oncol Biol Phys. 1981 Dec;7(12):1633-8
6174490
Semin Oncol. 2002 Dec;29(6 Suppl 16):15-8
12516034
Science. 2004 Aug 20;305(5687):1163-7
15284455
J Clin Oncol. 2005 Apr 10;23(11):2513-20
15738541
J Clin Oncol. 2004 Mar 15;22(6):1103-9
15020612
Br J Cancer. 2004 Dec 13;91(12):2026-33
15545965
Cell. 2000 Jan 7;100(1):57-70
10647931
AJNR Am J Neuroradiol. 1993 May-Jun;14(3):540-2
8517338
Neuroradiology. 1997 Jun;39(6):437-40
9225326
Clin Cancer Res. 2002 Oct;8(10):3250-8
12374696
AMA Arch Neurol Psychiatry. 1951 Feb;65(2):161-73
14798993
Int J Radiat Oncol Biol Phys. 1980 Jan;6(1):1-9
6154024
Br J Cancer. 2003 Dec;89 Suppl 2:S15-8
14661048
J Clin Oncol. 2003 Jun 15;21(12):2237-46
12748244
Neurology. 2005 Jul 12;65(1):165
16009912